Oncora Medical builds oncology AI products, Registry AI and Clinical AI, for cancer registries and clinical teams in Philadelphia.
Founded in 2014 and headquartered in Philadelphia, US, Oncora Medical develops oncology-specific artificial intelligence tools that improve clinical workflows and cancer data management. Registry AI optimizes data collection and analysis for cancer registries, and Clinical AI includes an AI scribe for oncology documentation. Christopher Berlind founded the company, David Lindsay is CEO, and it has raised USD 1.2 mn in Seed funding, most recently on March 10, 2016, from iSeed Ventures and BioAdvance. The listed stage is Seed.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in